Lopressor: Difference between revisions

Metoprolol
Clinical data
Trade names	Lopressor, Toprol-xl
AHFS/Drugs.com	Monograph
MedlinePlus	a682864
[[Regulation of therapeutic goods \|Template:Engvar data]]	US FDA: Metoprolol;
Pregnancy; category	AU: C ; US: C (Risk not ruled out) ; ;
Routes of; administration	Oral, IV
ATC code	C07AB02 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	12%
Metabolism	Hepatic via CYP2D6, CYP3A4
Elimination half-life	3-7 hours
Excretion	Renal
Identifiers
	IUPAC name (RS)-1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;
CAS Number	51384-51-1 ;
PubChem CID	4171;
IUPHAR/BPS	553;
DrugBank	DB00264 ;
ChemSpider	4027 ;
UNII	GEB06NHM23;
KEGG	D02358 ;
ChEBI	CHEBI:6904 ;
ChEMBL	ChEMBL13 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.364 g/mol
3D model (JSmol)	Interactive image;
Melting point	120 °C (248 °F)
	SMILES O(c1ccc(cc1)CCOC)CC(O)CNC(C)C;
	InChI InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 ; Key:IUBSYMUCCVWXPE-UHFFFAOYSA-N ;
(verify)

VisualWikitext

Revision as of 17:49, 17 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For information about metoprolol, click here.

Disclaimer

Black Box Warning

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Off-Label Use and Dosage (Pediatric)

FDA-Labeled Indications

Off-Label Use

Contraindications

Warnings and Precautions

Warnings

Precautions

Pregnancy Category

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

Drug Interactions

Use in Specific Populations

Pregnancy

Labor and Delivery

Nursing Mothers

Pediatric Use

Geriatric Use

Gender

Race

Renal Impairment

Hepatic Impairment

Females of Reproductive Potential and Males

Immunocompromised Patients

Mechanism of Action

Forms and Administration

Forms

Administration

Overdosage

Description

Clinical Pharmacology

Nonclinical Toxicology

Clinical Studies

How Supplied/Storage and Handling

Patient Counseling Information

Labels and Packages

Price

Pill Images and Characteristics

Look-Alike Drug Names

IV compatibility

@@ Line 42: / Line 42: @@
 ==[[Lopressor drug interactions|Drug Interactions]]==
-==[[Lopressor mechanism of action|Mechanism of Action]]==
-==[[Lopressor forms and administration|Forms and Administration]]==
-===[[Lopressor forms and administration#Forms|Forms]]===
-===[[Lopressor forms and administration#administration|Administration]]===
 ==[[Lopressor use in specific populations|Use in Specific Populations]]==
@@ Line 74: / Line 66: @@
 ===[[Lopressor dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]===
+==[[Lopressor mechanism of action|Mechanism of Action]]==
+==[[Lopressor forms and administration|Forms and Administration]]==
+===[[Lopressor forms and administration#Forms|Forms]]===
+===[[Lopressor forms and administration#administration|Administration]]===

Lopressor: Difference between revisions

Revision as of 17:49, 17 March 2014

Navigation menu